Published for Review and Comments: MolDX: Minimal Residual Disease Testing for Cancer -Proposed LCD and Billing and Coding Article

The following proposed Local Coverage Determinations (LCDs) have been published for review and comments for contract numbers: 02102 (AK), 03102 (AZ), 02202 (ID), 03202 (MT), 03302 (ND), 02302 (OR), 03402 (SD), 03502 (UT), 02402 (WA), and 03602 (WY).

Medicare Coverage Database Number LCD Title
DL38816 MolDX: Minimal Residual Disease Testing for Cancer

 

Medicare Coverage Database Number Billing and Coding Article Title
DA58456 Billing and Coding: MolDX: Minimal Residual Disease Testing for Cancer

 

Comment Period: October 8, 2020 – November 22, 2020

View the CMS MCD to access Proposed LCDs not released to final LCDs.  

Providers may address details for comment submission. When sending comments, reference the specific policy to which they are related. See the Proposed LCDs webpage for email and mail specifics.

            Last Updated Thu, 01 Oct 2020 16:09:50 +0000